Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Elizabeth T. Masters, Arvind Ramaprasan, Jack Mardekian, Roy E. Palmer, David E. Gross, David Cronkite, Michael Von Korff & David S. Carrell. (2018) Natural Language Processing–Identified Problem Opioid Use and Its Associated Health Care Costs. Journal of Pain & Palliative Care Pharmacotherapy 32:2-3, pages 106-115.
Read now
Read now
Ankit Shah, Margaret Duncan, Nipun Atreja, Kei Sing Tai & Mugdha Gore. (2018) Healthcare utilization and costs associated with treatment for opioid dependence. Journal of Medical Economics 21:4, pages 406-415.
Read now
Read now
John A. Carter, Ryan Dammerman & Michael Frost. (2017) Cost-effectiveness of subdermal implantable buprenorphine versus sublingual buprenorphine to treat opioid use disorder. Journal of Medical Economics 20:8, pages 893-901.
Read now
Read now
Carl L. Roland, Joanita Lake & Gary M. Oderda. (2016) Prevalence of Prescription Opioid Misuse/Abuse as Determined by International Classification of Diseases Codes: A Systematic Review. Journal of Pain & Palliative Care Pharmacotherapy 30:4, pages 258-268.
Read now
Read now
Jordan B. King, Amy M. Sainski-Nguyen & Brandon K. Bellows. (2016) Office-Based Buprenorphine Versus Clinic-Based Methadone: A Cost-Effectiveness Analysis. Journal of Pain & Palliative Care Pharmacotherapy 30:1, pages 55-65.
Read now
Read now
Gary M. Oderda, Joanita Lake, Katja Rüdell, Carl L. Roland & Elizabeth T. Masters. (2015) Economic Burden of Prescription Opioid Misuse and Abuse: A Systematic Review. Journal of Pain & Palliative Care Pharmacotherapy 29:4, pages 388-400.
Read now
Read now
Articles from other publishers (17)
C.N. Chatterton & R.P. Handy. (2023) Fentanyl concentrations in ligated femoral blood in the presence and absence of NPS benzodiazepine drugs. A review of over 1250 benzo-dope / fentanyl toxicity cases in Alberta, Canada. Forensic Science International 350, pages 111777.
Crossref
Crossref
A B M Rezbaul Islam, Khalid M Khan, Amanda Scarbrough, Mariah Jade Zimpfer, Navya Makkena, Adebola Omogunwa & Sheikh Iqbal Ahamed. (2023) An Artificial Intelligence–Based Smartphone App for Assessing the Risk of Opioid Misuse in Working Populations Using Synthetic Data: Pilot Development Study. JMIR Formative Research 7, pages e45434.
Crossref
Crossref
Jing Xu, Nazik M. A. Zakari, Hanadi Y. Hamadi, Sinyoung Park, Donald Rob Haley & Mei Zhao. (2021) The Financial Burden of Opioid-Related Abuse among Surgical and Non-Surgical Patients in Florida: A Longitudinal Study. International Journal of Environmental Research and Public Health 18:17, pages 9127.
Crossref
Crossref
Erica N. Onuoha, Jared A. Leff, Bruce R. Schackman, Kathryn E. McCollister, Daniel Polsky & Sean M. Murphy. (2021) Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review. Value in Health 24:7, pages 1068-1083.
Crossref
Crossref
Chad M BrummettJackie Evans-ShieldsChristina EnglandAmanda M KongCarolyn R LewCaroline HenriquesNicole M ZimmermanEric C Sun. (2021) Increased health care costs associated with new persistent opioid use after major surgery in opioid-naive patients. Journal of Managed Care & Specialty Pharmacy 27:6, pages 760-771.
Crossref
Crossref
Curtis Florence, Feijun Luo & Ketra Rice. (2021) The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017. Drug and Alcohol Dependence 218, pages 108350.
Crossref
Crossref
Aziza Arifkhanova, Emily McCormick Kraus, Alia Al-Tayyib, Julie Taub, Annette Encinias, Dean McEwen, Arthur Davidson & Judith C. Shlay. (2021) Estimating costs of hospitalizations associated with opioid use disorder or opioid misuse at a large, urban safety-net hospital—Denver, Colorado, 2017. Drug and Alcohol Dependence 218, pages 108306.
Crossref
Crossref
Hildi Hagedorn, Marie Kenny, Adam J. Gordon, Princess E. Ackland, Siamak Noorbaloochi, Wei Yu & Alex H. S. Harris. (2018) Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities. Addiction Science & Clinical Practice 13:1.
Crossref
Crossref
Marcia Reinhart, Lauren M. Scarpati, Noam Y. Kirson, Cody Patton, Nina Shak & Jennifer G. Erensen. (2018) The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017. Applied Health Economics and Health Policy 16:5, pages 609-632.
Crossref
Crossref
Corey S. Davis & Derek H. Carr. (2017) The Law and Policy of Opioids for Pain Management, Addiction Treatment, and Overdose Reversal. Indiana Health Law Review 14:1, pages 1.
Crossref
Crossref
Kathryn G. MuellerStavros G. MemtsoudisEdward R. MarianoLaurence C. BakerSean MackeyEric C. Sun. (2017) Lack of Association Between the Use of Nerve Blockade and the Risk of Persistent Opioid Use Among Patients Undergoing Shoulder Arthroplasty: Evidence From the Marketscan Database. Anesthesia & Analgesia 125:3, pages 1014-1020.
Crossref
Crossref
Cheryl J. Isenhour, Susan H. Hariri, Craig M. Hales & Claudia J. Vellozzi. (2017) Hepatitis C Antibody Testing in a Commercially Insured Population, 2005–2014. American Journal of Preventive Medicine 52:5, pages 625-631.
Crossref
Crossref
Martin E Hale, Derek Moe, Mary Bond, Maciej Gasior & Richard Malamut. (2016) Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain. Pain Management 6:5, pages 497-508.
Crossref
Crossref
Curtis S. Florence, Chao Zhou, Feijun Luo & Likang Xu. (2016) The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013. Medical Care 54:10, pages 901-906.
Crossref
Crossref
Janice L. Clarke, Alexis Skoufalos & Richard Scranton. (2016) The American Opioid Epidemic: Population Health Implications and Potential Solutions. Report from the National Stakeholder Panel. Population Health Management 19:S1, pages S-1-S-10.
Crossref
Crossref
Amie Shei, J. Bradford Rice, Noam Y. Kirson, Katharine Bodnar, Caroline J. Enloe, Howard G. Birnbaum, Pamela Holly & Rami Ben-Joseph. (2015) Characteristics of High-Cost Patients Diagnosed with Opioid Abuse. Journal of Managed Care & Specialty Pharmacy 21:10, pages 902-912.
Crossref
Crossref
Noam Y. Kirson, Amie Shei, J. Bradford Rice, Caroline J. Enloe, Katharine Bodnar, Howard G. Birnbaum, Pamela Holly & Rami Ben-Joseph. (2015) The Burden of Undiagnosed Opioid Abuse Among Commercially Insured Individuals. Pain Medicine 16:7, pages 1325-1332.
Crossref
Crossref